blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1699921

EP1699921 - A METHOD FOR THE PREPARATION OF CROSS LINKED PROTEIN CRYSTALS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.09.2010
Database last updated on 22.08.2024
Most recent event   Tooltip10.09.2010No opposition filed within time limitpublished on 13.10.2010  [2010/41]
Applicant(s)For all designated states
Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860)
Rafi Marg
New Delhi 110 001 / IN
[N/P]
Former [2006/37]For all designated states
Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860)
Rafi Marg
New Delhi 110 001 / IN
Inventor(s)01 / ABRAHAM, Tholath, Emilia, Regional Research Lab.
Industrial Estate (PO)
Trivandrum 695 019, Kerala / IN
02 / BINDHU, Lekshmibai, V. A., Regional Research Lab.
Industrial Estate (PO)
Trivandrum 695 019, Kerala / IN
 [2006/37]
Representative(s)Winter, Brandl - Partnerschaft mbB
Alois-Steinecker-Straße 22
85354 Freising / DE
[N/P]
Former [2006/37]Winter, Brandl, Fürniss, Hübner Röss, Kaiser, Polte Partnerschaft Patent- und Rechtsanwaltskanzlei
Alois-Steinecker-Strasse 22
85354 Freising / DE
Application number, filing date04700022.901.01.2004
[2006/37]
WO2004IN00002
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005066341
Date:21.07.2005
Language:EN
[2005/29]
Type: A1 Application with search report 
No.:EP1699921
Date:13.09.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.07.2005 takes the place of the publication of the European patent application.
[2006/37]
Type: B1 Patent specification 
No.:EP1699921
Date:04.11.2009
Language:EN
[2009/45]
Search report(s)International search report - published on:EP21.07.2005
ClassificationIPC:C12N11/00, C12N9/02, C12N9/34
[2006/37]
CPC:
C12N9/0065 (EP,US); C07K1/1077 (EP,US); C12N9/2428 (EP,US);
C12N9/96 (EP,US); C12P19/02 (EP,US); C12P19/14 (EP,US)
Designated contracting statesDE,   DK,   NL [2007/14]
Former [2006/37]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:METHODE ZUR HERSTELLUNG VON QUERVERNETZTEN PROTEIN KRISTALLEN[2006/37]
English:A METHOD FOR THE PREPARATION OF CROSS LINKED PROTEIN CRYSTALS[2006/37]
French:PROCEDE POUR L'ELABORATION DE CRISTAUX DE PROTEINES RETICULES[2006/37]
Entry into regional phase13.07.2006National basic fee paid 
13.07.2006Designation fee(s) paid 
13.07.2006Examination fee paid 
Examination procedure12.07.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.07.2006Examination requested  [2006/37]
11.12.2006Despatch of a communication from the examining division (Time limit: M04)
23.04.2007Reply to a communication from the examining division
26.06.2007Despatch of a communication from the examining division (Time limit: M06)
07.01.2008Reply to a communication from the examining division
01.04.2008Despatch of a communication from the examining division (Time limit: M04)
16.07.2008Reply to a communication from the examining division
12.09.2008Despatch of a communication from the examining division (Time limit: M04)
19.01.2009Reply to a communication from the examining division
15.05.2009Communication of intention to grant the patent
22.09.2009Fee for grant paid
22.09.2009Fee for publishing/printing paid
Opposition(s)05.08.2010No opposition filed within time limit [2010/41]
Fees paidRenewal fee
13.07.2006Renewal fee patent year 03
26.01.2007Renewal fee patent year 04
28.01.2008Renewal fee patent year 05
30.01.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9912959  (ALTUS BIOLOGICS INC [US], et al) [X] 1-22 * examples 1-4 *;
 [X]WO9202617  (VERTEX PHARMA [US]) [X] 1-22 * examples 1-7; tables 1-5 *;
 US5849296  [ ] (NAVIA MANUEL A [US], et al);
 [X]US5932212  (KHALAF NAZER K [US]) [X] 1-22 * examples 1-10 *;
 US6042824  [ ] (KHALAF NAZER K [US]);
 [X]  - MARGOLIN A L, "Novel crystalline catalysts", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (19960701), vol. 14, no. 7, ISSN 0167-7799, pages 223 - 230, XP004035759 [X] 1-22 * the whole document * * tables 1,2 *

DOI:   http://dx.doi.org/10.1016/0167-7799(96)10031-7
 [PX]  - ABRAHAM T E ET AL, "Crosslinked enzyme crystals of glucoamylase as a potent catalyst for biotransformations", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, (20040428), vol. 339, no. 6, ISSN 0008-6215, pages 1099 - 1104, XP004500589 [PX] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.carres.2004.01.011
 [A]  - MARGOLIN, ALEXEY L. ET AL, "Protein crystals as novel catalytic materials", ANGEWANDTE CHEMIE, INTERNATIONAL EDITION , 40 (12), 2204 -2222 CODEN: ACIEF5; ISSN: 1433-7851, (2001), XP002296964 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1002/1521-3773(20010618)40:12<2204::AID-ANIE2204>3.0.CO;2-J
 [A]  - GOVARDHAN CHANDRIKA P, "Crosslinking of enzymes for improved stability and performance", CURRENT OPINION IN BIOTECHNOLOGY, (199908), vol. 10, no. 4, ISSN 0958-1669, pages 331 - 335, XP002296965 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0958-1669(99)80060-3
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.